The latest Investing Matters Podcast episode with multi-award-winning fund manager and international bestselling author Lee Freeman-Shor has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,185.00
Bid: 1,180.00
Ask: 1,182.00
Change: 22.00 (1.89%)
Spread: 2.00 (0.169%)
Open: 1,163.00
High: 1,190.00
Low: 1,159.00
Prev. Close: 1,163.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

14 Mar 2024 16:06

RNS Number : 9353G
Indivior PLC
14 March 2024

INDIVIOR PLC (THE 'COMPANY')

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ('PDMR') AND PERSONS CLOSELY ASSOCIATED WITH THEM

The Company announces that on March 14, 2024, Conditional Awards ('Awards') over Ordinary Shares of $0.50 each ('Shares') were granted to the Executive Directors set out below under the Indivior Deferred Bonus Plan 2018 (the 'DBP').

Awards granted under the DBP represent the deferral of 25% of the gross bonus earned under the Indivior 2023 Annual Incentive Plan. The Awards will normally vest on the second anniversary of the Award date and are subject to continued employment. No consideration is payable either on the grant or vesting of the Awards.

Name

Number of Shares under Award

Executive Directors

Mark Crossley

16,959

Ryan Preblick

6,302

This notification is made in accordance with the requirements of the UK Market Abuse Regulation.

Kathryn Hudson

Company Secretary

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Mark Crossley

2

Reason for the notification

a)

Position/status

Director / PDMR - Chief Executive Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Indivior PLC

b)

LEI

213800V3NCQTY7IED471

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of US$0.50

GB00BN4HT335

b)

Nature of the transaction

Grant of a conditional Award over Ordinary Shares under the Indivior Deferred Bonus Plan 2018.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

16,959

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

March 14, 2024

f)

Place of the transaction

N/A

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Ryan Preblick

2

Reason for the notification

a)

Position/status

Director / PDMR - Chief Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Indivior PLC

b)

LEI

213800V3NCQTY7IED471

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of US$0.50

GB00BN4HT335

b)

Nature of the transaction

Grant of a conditional Award over Ordinary Shares under the Indivior Deferred Bonus Plan 2018.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

N/A

6,302

d)

Aggregated information

- Aggregated volume

- Price

N/A

e)

Date of the transaction

March 14, 2024

f)

Place of the transaction

N/A

Indivior PLC's Legal Entity Identifier code is 213800V3NCQTY7IED471.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHGPUCUWUPCGQC
Date   Source Headline
10th Aug 20183:38 pmRNSHolding(s) in Company
6th Aug 20184:19 pmRNSHolding(s) in Company
1st Aug 20187:00 amRNSTotal Voting Rights
31st Jul 20187:00 amRNSIndivior Preliminary Injunction Upheld
30th Jul 20187:01 amRNSDRL's Appeal of Indivior's PI Granted-in-Part
30th Jul 20187:00 amRNSUS FDA Approves Indivor's PERSERIS(TM)
27th Jul 20188:40 amRNSHolding(s) in Company
26th Jul 20189:01 amRNSHolding(s) in Company
25th Jul 20187:00 amRNSHalf-year Report
24th Jul 20187:00 amRNSHolding(s) in Company
16th Jul 20187:00 amRNSUS Court Grants Indivior Preliminary Injunction
13th Jul 20184:39 pmRNSHolding(s) in Company
12th Jul 20185:16 pmRNSHolding(s) in Company
11th Jul 20187:00 amRNSIndivior Sees FY18 Guidance Below Expectations
10th Jul 20187:00 amRNSNotice of Results
3rd Jul 20187:01 amRNSHolding(s) in Company
3rd Jul 20187:00 amRNSHolding(s) in Company
29th Jun 20187:00 amRNSIndivior's Temporary Restraining Order is Extended
21st Jun 20182:56 pmRNSHolding(s) in Company
20th Jun 20187:00 amRNSHolding(s) in Company
18th Jun 20187:00 amRNSIndivior Is Granted Temporary Restraining Order
15th Jun 20183:56 pmRNSHolding(s) in Company
15th Jun 20181:59 pmRNSIndivior Responds to Generic SUBOXONE ® Approvals
7th Jun 20189:30 amRNSHolding(s) in Company
1st Jun 20187:00 amRNSTotal Voting Rights
31st May 20187:00 amRNSCalifornia Department of Insurance subpoena
25th May 20182:25 pmRNSSUBLOCADE(TM) Submitted in Australia for Approval
24th May 20187:00 amRNSIndivior Participating in Jefferies NYC Conference
16th May 20185:50 pmRNSResult of AGM
14th May 20187:00 amRNSIndivior settlement with Par Pharmaceutical
10th May 201811:40 amRNSBlock listing Interim Review
4th May 20182:13 pmRNSDirector/PDMR Shareholding
2nd May 20187:00 amRNS1st Quarter Results
20th Apr 20187:00 amRNSIndivior's SUBLOCADE NDS Accepted by Health Canada
12th Apr 20183:56 pmRNSHolding(s) in Company
11th Apr 20184:02 pmRNSDirector Declaration
11th Apr 20187:00 amRNSNotice of Results
6th Apr 20189:31 amRNSHolding(s) in Company
5th Apr 20187:00 amRNSIndivior Asserts New SUBOXONE(R) Film Patent
4th Apr 20189:28 amRNSDirector/PDMR Shareholding
3rd Apr 20189:33 amRNSHolding(s) in Company
3rd Apr 20187:00 amRNSTotal Voting Rights
29th Mar 20187:00 amRNSIndivior and C4X Enter Licensing Agreement
27th Mar 20184:13 pmRNSHolding(s) in Company
23rd Mar 20187:00 amRNSIndivior Responds to Court Ruling ANDA litigation
22nd Mar 20181:39 pmRNSAnnual Financial Report
13th Mar 20183:14 pmRNSDirector/PDMR Shareholding
12th Mar 20184:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20182:51 pmRNSHolding(s) in Company
2nd Mar 201810:24 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.